Company / Free Cash Flow
BeOne Medicines Ltd. Free Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
$941.7M
FY2025
5-year range
-$1.8B / $941.7M
FY2021-FY2025
Trend
+248.7%
vs FY2024
Sector context
#17 of 194
Health Care
What the data says
Free Cash Flow changed +249% YoY in FY2025, a notable deviation from the 9-year average annual change of -165%.
Based on SEC 10-K filings.
$942M in FY2025. Top quartile in the Health Care sector.
Improved from -$1.7B to $942M over the past 2 years.
Health Care sector context is included.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 9% in Health CareTop 9% of 194This company $941.7M Sector average $470.8M
▼
+100.0% above sector average
Key checks
Key Insights
- BeOne Medicines Ltd.'s free cash flow has grown for 3 consecutive years.
- In FY2025, free cash flow increased 248.7% year-over-year.
- Ranks #17 out of 194 companies in the Health Care sector.
- Lowest free cash flow in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score 0.82 (distress zone, below 1.8 threshold)
- Negative profit margin: -16.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $941.7M | +248.7% |
| FY2024 | -$633.3M | +63.2% |
| FY2023 | -$1.7B | +5.6% |
| FY2022 | -$1.8B | -16.7% |
| FY2021 | -$1.6B | -11.5% |
| FY2020 | -$1.4B | -66.8% |
| FY2019 | -$839.9M | -35.9% |
| FY2018 | -$618.0M | -1738.1% |
| FY2017 | -$33.6M | +70.2% |
| FY2016 | -$113.0M | -150.3% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026